-
3-(3-bromo-4-hydroxyphenyl)-N-[2-({2-[3-(3-bromo-4-hydroxyphenyl)-2-(N-hydroxyimino)propanamido]ethyl}disulfanyl)ethyl]-2-(N-hydroxyimino)propanamide
-
ChemBase ID:
153164
-
Molecular Formular:
C22H24Br2N4O6S2
-
Molecular Mass:
664.38716
-
Monoisotopic Mass:
661.95040051
-
SMILES and InChIs
SMILES:
c1c(cc(c(c1)O)Br)C/C(=N/O)/C(=O)NCCSSCCNC(=O)/C(=N\O)/Cc1cc(c(cc1)O)Br
Canonical SMILES:
O/N=C(\C(=O)NCCSSCCNC(=O)/C(=N\O)/Cc1ccc(c(c1)Br)O)/Cc1ccc(c(c1)Br)O
InChI:
InChI=1S/C22H24Br2N4O6S2/c23-15-9-13(1-3-19(15)29)11-17(27-33)21(31)25-5-7-35-36-8-6-26-22(32)18(28-34)12-14-2-4-20(30)16(24)10-14/h1-4,9-10,29-30,33-34H,5-8,11-12H2,(H,25,31)(H,26,32)
InChIKey:
LMAFSGDNHVBIHU-UHFFFAOYSA-N
-
Cite this record
CBID:153164 http://www.chembase.cn/molecule-153164.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
3-(3-bromo-4-hydroxyphenyl)-N-[2-({2-[3-(3-bromo-4-hydroxyphenyl)-2-(N-hydroxyimino)propanamido]ethyl}disulfanyl)ethyl]-2-(N-hydroxyimino)propanamide
|
|
|
IUPAC Traditional name
|
3-(3-bromo-4-hydroxyphenyl)-N-[2-({2-[3-(3-bromo-4-hydroxyphenyl)-2-(N-hydroxyimino)propanamido]ethyl}disulfanyl)ethyl]-2-(N-hydroxyimino)propanamide
|
|
|
Synonyms
|
Bisprasin, N,N"-(dithiodi-2,1-ethanediyl)bis[3-bromo-4-hydroxy-a-(hydroxyimino)-benzenepropanamide
|
Psammaplin A
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
6.273931
|
H Acceptors
|
8
|
H Donor
|
6
|
LogD (pH = 5.5)
|
4.0113583
|
LogD (pH = 7.4)
|
2.2065783
|
Log P
|
4.081383
|
Molar Refractivity
|
149.0862 cm3
|
Polarizability
|
56.860638 Å3
|
Polar Surface Area
|
163.84 Å2
|
Rotatable Bonds
|
13
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
P8749
|
Biochem/physiol Actions Psammaplin A is an antibiotic, anti-tumor, DNA methyltransferase inhibitor. It is a bromotyrosine-derived, symmetrical conjugate of cystamine, which was first isolated from the Psammaplinaplysilla sponge. Psammaplin A impedes angiogenesis as well as bacterial and tumor cell growth. Psammaplin A inhibits the activities of several key enzymes in prokaryotic and eukaryotic systems including those involved in epigenetic control of gene expression, DNA replication, angiogensis, and microbial detoxification. |
PATENTS
PATENTS
PubChem Patent
Google Patent